C21H13F9N4O5S — CID 162726575
2-[3-nitro-5-(trifluoromethyl)-6-(trifluoromethylsulfanyloxy)-2-pyridinyl]-5-(1,1,1-trifluoro-2-phenylmethoxypent-4-en-2-yl)-1,3,4-oxadiazole (PubChem CID 162726575) has the molecular formula C21H13F9N4O5S and a molecular weight of 604.41 g/mol. Its IUPAC name is 2-[3-nitro-5-(trifluoromethyl)-6-(trifluoromethylsulfanyloxy)-2-pyridinyl]-5-(1,1,1-trifluoro-2-phenylmethoxypent-4-en-2-yl)-1,3,4-oxadiazole.
| Compound Name | 2-[3-nitro-5-(trifluoromethyl)-6-(trifluoromethylsulfanyloxy)-2-pyridinyl]-5-(1,1,1-trifluoro-2-phenylmethoxypent-4-en-2-yl)-1,3,4-oxadiazole |
|---|---|
| PubChem CID | 162726575 |
| Molecular Formula | C21H13F9N4O5S |
| Molecular Weight | 604.41 g/mol |
| Exact Mass | 604.05 |
| IUPAC Name | 2-[3-nitro-5-(trifluoromethyl)-6-(trifluoromethylsulfanyloxy)-2-pyridinyl]-5-(1,1,1-trifluoro-2-phenylmethoxypent-4-en-2-yl)-1,3,4-oxadiazole |
| SMILES | C=CCC(OCc1ccccc1)(c1nnc(-c2nc(OSC(F)(F)F)c(C(F)(F)F)cc2[N+](=O)[O-])o1)C(F)(F)F |
| InChI | InChI=1S/C21H13F9N4O5S/c1-2-8-18(20(25,26)27,37-10-11-6-4-3-5-7-11)17-33-32-16(38-17)14-13(34(35)36)9-12(19(22,23)24)15(31-14)39-40-21(28,29)30/h2-7,9H,1,8,10H2 |
| InChIKey | PCUHOHYHFGGPKI-UHFFFAOYSA-N |
| XLogP | 7.16 |
| TPSA | 113.41 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 40 |
| Complexity | — |
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 604.41 |
| LogP ≤ 5 | 7.16 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 9 |
| Structural Alerts | {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'sulfur_oxygen_single_bond', 'substructure': 'N/A'} |
|---|